Partner therapeutics, INC.: .: barda drive : research and development of diagnostic tests for patients with sepsis and immunoparalysis
Ended Definitive Contract Awarded Last action
- Contract number
- 75A50121C00080
- Awardee
-
Partner Therapeutics, Inc. UEI J33MSDBJZMC6
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $748,912
Award facts
- Opportunity
-
- BARDA's Division of Research, Innovation & Ventures (DRIVe) Easy Broad Agency Announcement Solicitation · BAA20100SOL0002 · Posted Feb 3, 2020
- Contract value 100% obligated
- $748,912.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 100 offers Basic Research
- Pricing
- Firm Fixed Price
- Place of performance
- Lexington, MA 02421, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $748,912 |
About this award
Partner Therapeutics, Inc. was awarded a $748,912 definite contract by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to conduct research and development of diagnostic tests for patients with sepsis and immunoparalysis. The contract was awarded under Special Instructions 019 of the agency's Easy Broad Agency Announcement BAA-20-100-SOL-0002 vehicle. Special Instructions 019 sought host-directed therapeutic candidates to aid long-term outcomes from lung injury through Area of Interest 12 by facilitating safety review through Phase I clinical trials and sharing of data and commercialization plans. Work will be performed by Partner Therapeutics in Lexington, Massachusetts over a period of performance from September 2021 through July 2023. No subcontractors or set aside designations were identified.
Quick answers
Who was awarded contract 75A50121C00080?
75A50121C00080 was awarded to Partner Therapeutics, Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 2, 2021.
How much is contract 75A50121C00080 worth?
The government has obligated $748,912 on 75A50121C00080.
Was contract 75A50121C00080 competed?
The extent of competition for 75A50121C00080 was full and open competition. The government received 100 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award